Capital World Investors’s Twist Bioscience TWST Stock Holding History

Capital World Investors’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-704,000	Closed	-$16.8M	–	545
2022 Q4	$16.8M	Hold	704,000	–	–	﹤0.01%	467
2022 Q3	$24.8M	Hold	704,000	–	–	0.01%	443
2022 Q2	$24.6M	Sell	704,000 -4,091,848	-85%	-$145M	0.01%	451
2022 Q1	$237M	Buy	4,795,848 +273,148	+6%	+$15.1M	0.04%	280
2021 Q4	$350M	Buy	4,522,700 +182,684	+4%	+$18.8M	0.06%	255
2021 Q3	$464M	Sell	4,340,016 -182,676	-4%	-$20.9M	0.08%	222
2021 Q2	$603M	Buy	4,522,692 +1,179,568	+35%	+$137M	0.1%	193
2021 Q1	$414M	Buy	3,343,124 +393,852	+13%	+$59.8M	0.08%	218
2020 Q4	$417M	Buy	2,949,272 +1,339,320	+83%	+$149M	0.08%	218
2020 Q3	$122M	Buy	1,609,952 +905,952	+129%	+$56.4M	0.03%	314
2020 Q2	$31.9M	Hold	704,000	–	–	0.01%	393
2020 Q1	$21.5M	Hold	704,000	–	–	0.01%	386
2019 Q4	$14.8M	Buy	+704,000	New	+$16.5M	﹤0.01%	446

Other funds holding TWST

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Capital World Investors's TWST Position: Q1 2023 in Review

Capital World Investors sold out of Twist Bioscience (TWST) in Q1 2023, closing a stake of 704,000 shares — an estimated $16.8M sold.

Capital World Investors first reported a position in TWST in Q4 2019 and held it in 13 quarters. The position peaked at $603M in Q2 2021. 201 funds tracked by Wall St. Rank hold TWST as of Q1 2023.

Capital World Investors reported no remaining Twist Bioscience position as of Q1 2023 after selling out during the quarter.
Capital World Investors sold 704,000 Twist Bioscience shares in Q1 2023, an estimated $16.8M.
Capital World Investors first reported a position in Twist Bioscience in Q4 2019 and held it in 13 quarters.
Capital World Investors's Twist Bioscience position peaked at $603M in Q2 2021.
201 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2023.

Based on Capital World Investors's 13F filing for Q1 2023, filed 15 May 2023.